189 related articles for article (PubMed ID: 35079008)
1. A combination of multiple autoantibodies is associated with the risk of Alzheimer's disease and cognitive impairment.
Shim SM; Koh YH; Kim JH; Jeon JP
Sci Rep; 2022 Jan; 12(1):1312. PubMed ID: 35079008
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
4. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
Bos I; Vos S; Vandenberghe R; Scheltens P; Engelborghs S; Frisoni G; Molinuevo JL; Wallin A; Lleó A; Popp J; Martinez-Lage P; Baird A; Dobson R; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Bertram L; Ten Kate M; Barkhof F; Zetterberg H; Lovestone S; Streffer J; Visser PJ
Alzheimers Res Ther; 2018 Jul; 10(1):64. PubMed ID: 29980228
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
[TBL] [Abstract][Full Text] [Related]
6. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
Kim YS; Lee KJ; Kim H
Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
[TBL] [Abstract][Full Text] [Related]
7. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
[TBL] [Abstract][Full Text] [Related]
8. A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
Abe K; Shang J; Shi X; Yamashita T; Hishikawa N; Takemoto M; Morihara R; Nakano Y; Ohta Y; Deguchi K; Ikeda M; Ikeda Y; Okamoto K; Shoji M; Takatama M; Kojo M; Kuroda T; Ono K; Kimura N; Matsubara E; Osakada Y; Wakutani Y; Takao Y; Higashi Y; Asada K; Senga T; Lee LJ; Tanaka K
J Alzheimers Dis; 2020; 73(1):217-227. PubMed ID: 31771070
[TBL] [Abstract][Full Text] [Related]
9. A Novel Plasma Based Biomarker of Alzheimer's Disease.
Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
[TBL] [Abstract][Full Text] [Related]
10. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease.
McIntyre JA; Ramsey CJ; Gitter BD; Saykin AJ; Wagenknecht DR; Hyslop PA;
Autoimmunity; 2015; 48(5):344-51. PubMed ID: 25672931
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
Giil LM; Kristoffersen EK; Vedeler CA; Aarsland D; Nordrehaug JE; Winblad B; Cedazo-Minguez A; Lund A; Reksten TR
J Alzheimers Dis; 2015; 47(2):523-9. PubMed ID: 26401573
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against small heat-shock proteins in Alzheimer's disease as a part of natural human immune repertoire or activation of humoral response?
Papuć E; Krupski W; Kurys-Denis E; Rejdak K
J Neural Transm (Vienna); 2016 Apr; 123(4):455-61. PubMed ID: 26566902
[TBL] [Abstract][Full Text] [Related]
14. Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer's Disease Progression.
Nam E; Lee YB; Moon C; Chang KA
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679907
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
16. Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
DeMarshall C; Oh E; Kheirkhah R; Sieber F; Zetterberg H; Blennow K; Nagele RG
PLoS One; 2019; 14(11):e0225178. PubMed ID: 31730624
[TBL] [Abstract][Full Text] [Related]
17. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
[TBL] [Abstract][Full Text] [Related]
18. HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.
Agostini S; Mancuso R; Hernis A; Costa AS; Nemni R; Clerici M
J Alzheimers Dis; 2018; 63(1):131-138. PubMed ID: 29578484
[TBL] [Abstract][Full Text] [Related]
19. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
20. Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.
Zabel M; Schrag M; Mueller C; Zhou W; Crofton A; Petersen F; Dickson A; Kirsch WM
J Alzheimers Dis; 2012; 30(2):311-21. PubMed ID: 22426016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
